Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 2006, p. 1887-1889, Vol. 50, No. 5
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.5.1887-1889.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
and
S. M. Finegold1,2,3,4*
Medical,1 Research Services, VA Greater Los Angeles Healthcare System,2 Departments of Medicine,3 Microbiology, Immunology and Molecular Genetics, UCLA School of Medicine, Los Angeles, California4
Received 3 October 2005/ Returned for modification 29 October 2005/ Accepted 9 March 2006
The activity of DX-619 was evaluated against 376 anaerobic isolates using the reference CLSI agar dilution method. Overall, 90% of the strains were susceptible to DX-619 at
1 µg/ml. It was more active than the other four compounds tested except for meropenem, which showed virtually identical overall activity.
Present address: Monseñor Sanabria Hospital, Puntarenas, Costa Rica.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»